C.M. Bidwell & Associates »

Xenon Pharmaceuticals shares owned by C.M. Bidwell & Associates

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by C.M. Bidwell & Associates from 13F filings

Historical chart of C.M. Bidwell & Associates investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by C.M. Bidwell & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by C.M. Bidwell & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $387 9 43.00

More positions owned by C.M. Bidwell & Associates

iShares Russell 1000 Index (IWB)
iShares Russell 2000 Index (IWM)
Vanguard Total Stock Market ETF (VTI)
Vanguard S&p 500 Etf idx (VOO)
Vanguard Short-Term Bond ETF (BSV)
iShares Brclys Intrdte Gov/Crt Bd (GVI)
Ishares Tr core strm usbd (ISTB)
Vanguard Europe Pacific ETF (VEA)
Vanguard Total Bond Market ETF (BND)
iShares MSCI ACWI ex US Index Fund (ACWX)
Vanguard Malvern Fds strm infproidx (VTIP)
Schwab U S Broad Market ETF (SCHB)
Dimensional Etf Trust (DFAC)
Schwab Strategic Tr us lrg cap etf (SCHX)
Schwab Strategic Tr 0 (SCHP)

View all positions for C.M. Bidwell & Associates

Top funds holding Xenon Pharmaceuticals

Driehaus Capital Management
Commodore Capital
Braidwell
BlackRock
Paradigm Biocapital Advisors
Alliancebernstein
T. Rowe Price Investment Management
Marshall Wace
First Light Asset Management
Rock Springs Capital Management
Henderson Group
Affinity Asset Advisors
Baker Bros. Advisors
Invesco
OrbiMed Advisors

View all funds holding Xenon Pharmaceuticals